160 related articles for article (PubMed ID: 38063308)
1. Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy.
Forson M; Bashiru M; Macchi S; Singh S; Anderson AD; Sayyed S; Ishtiaq A; Griffin R; Ali N; Oyelere AK; Berry B; Siraj N
ACS Appl Bio Mater; 2023 Dec; 6(12):5662-5675. PubMed ID: 38063308
[TBL] [Abstract][Full Text] [Related]
2. Improved Photophysical Properties of Ionic Material-Based Combination Chemo/PDT Nanomedicine.
Macchi S; Zubair M; Hill R; Alwan N; Khan Y; Ali N; Guisbiers G; Berry B; Siraj N
ACS Appl Bio Mater; 2021 Oct; 4(10):7708-7718. PubMed ID: 35006702
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin-Based Metal-Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy.
Yu W; Zhen W; Zhang Q; Li Y; Luo H; He J; Liu Y
ChemMedChem; 2020 Oct; 15(19):1766-1775. PubMed ID: 32715651
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted cationic porphyrin-triphenylamine hybrids for enhanced two-photon photodynamic therapy.
Hammerer F; Poyer F; Fourmois L; Chen S; Garcia G; Teulade-Fichou MP; Maillard P; Mahuteau-Betzer F
Bioorg Med Chem; 2018 Jan; 26(1):107-118. PubMed ID: 29174053
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Photophysical Properties and Application of New Porphyrin Derivatives for Use in Photodynamic Therapy and Cell Imaging.
Mahajan PG; Dige NC; Vanjare BD; Phull AR; Kim SJ; Hong SK; Lee KH
J Fluoresc; 2018 Jul; 28(4):871-882. PubMed ID: 30014275
[TBL] [Abstract][Full Text] [Related]
6. Reaction mechanism of nanomedicine based on porphyrin skeleton and its application prospects.
Li H; Xiao W; Tian Z; Liu Z; Shi L; Wang Y; Liu Y; Liu Y
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103236. PubMed ID: 36494023
[TBL] [Abstract][Full Text] [Related]
7. Cationic porphyrin-based nanoparticles for photodynamic inactivation and identification of bacteria strains.
Li L; Wang Y; Huang T; He X; Zhang K; Kang ET; Xu L
Biomater Sci; 2022 May; 10(11):3006-3016. PubMed ID: 35522076
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro PDT evaluation of new porphyrins containing meso-epoxymethylaryl cationic groups.
Carneiro J; Gonçalves A; Zhou Z; Griffin KE; Kaufman NEM; Vicente MDGH
Lasers Surg Med; 2018 Jul; 50(5):566-575. PubMed ID: 29691890
[TBL] [Abstract][Full Text] [Related]
9. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal.
Deng J; Li H; Yang M; Wu F
Photochem Photobiol Sci; 2020 Jul; 19(7):905-912. PubMed ID: 32369050
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria.
Rajaputra P; Nkepang G; Watley R; You Y
Bioorg Med Chem; 2013 Jan; 21(2):379-87. PubMed ID: 23245573
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution.
Lazzeri D; Rovera M; Pascual L; Durantini EN
Photochem Photobiol; 2004; 80(2):286-93. PubMed ID: 15362952
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Novel Cationic Photosensitizers Derived from Chlorin for Application in Photodynamic Therapy of Cancer.
Ranjbari F; Rashidi MR; Hemmati S; Safari E; Tajalli H
Curr Radiopharm; 2023; 16(4):315-325. PubMed ID: 37246330
[TBL] [Abstract][Full Text] [Related]
14. A new nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a potential sensitizer for photodynamic therapy.
Silva P; Fonseca SM; Arranja CT; Burrows HD; Urbano AM; Sobral AJ
Photochem Photobiol; 2010; 86(5):1147-53. PubMed ID: 20553404
[TBL] [Abstract][Full Text] [Related]
15. Organic small molecular nanoparticles based on self-assembly of amphiphilic fluoroporphyrins for photodynamic and photothermal synergistic cancer therapy.
Yang L; Li H; Liu D; Su H; Wang K; Liu G; Luo X; Wu F
Colloids Surf B Biointerfaces; 2019 Oct; 182():110345. PubMed ID: 31299540
[TBL] [Abstract][Full Text] [Related]
16. Photochemical /Photocytotoxicity Studies of New Tetrapyrrolic Structures as Potential Candidates for Cancer Theranostics.
Ferreira LFV; Machado IF; Gama A; Socoteanu RP; Boscencu R; Manda G; Calhelha RC; Ferreira ICFR
Curr Drug Discov Technol; 2020; 17(5):661-669. PubMed ID: 30973109
[TBL] [Abstract][Full Text] [Related]
17. The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.
Li MY; Mi L; Meerovich G; Soe TW; Chen T; Than NN; Yan YJ; Chen ZL
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2335-2346. PubMed ID: 35522290
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of New Porphyrin Analogues as Potent Photosensitizers for Photodynamic Therapy: Spectroscopic Approach.
Mahajan PG; Dige NC; Vanjare BD; Kim CH; Seo SY; Lee KH
J Fluoresc; 2020 Mar; 30(2):397-406. PubMed ID: 32088851
[TBL] [Abstract][Full Text] [Related]
19. Photophysical characterization and in vitro anti-leishmanial effect of 5,10,15,20-tetrakis(4-fluorophenyl) porphyrin and the metal (Zn(II), Sn(IV), Mn(III) and V(IV)) derivatives.
Espitia-Almeida F; Díaz-Uribe C; Vallejo W; Gómez-Camargo D; Bohórquez ARR; Zarate X; Schott E
Biometals; 2022 Feb; 35(1):159-171. PubMed ID: 34993713
[TBL] [Abstract][Full Text] [Related]
20. Random versus Block Glycopolymers Bearing Betulin and Porphyrin for Enhanced Photodynamic Therapy.
Ma Z; An R; Chen M; Wang X; Zhu M
Biomacromolecules; 2022 Dec; 23(12):5074-5083. PubMed ID: 36350056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
